Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum W
DAK-Gesundheit awarded a contract of undisclosed value to BG Hexal 1 A Pharma GbR for Healthcare & Medical in January 2026 — one of 389 awards this buyer has made.
Buying agency
DAK-GesundheitWinning supplier
BG Hexal 1 A Pharma GbRContract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Adapalen + Benzoylperoxid, ATC D10AD23 für die Zeit 01.02.2024 - 31.01.2026
Related awards · DAK-Gesundheit
389 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-210283-2024Aktivital GmbH€9.1M10 Apr 2024 Healthcare
- ocds-ted-211590-2024Kraaibeek GmbH€2.5M10 Apr 2024 Healthcare
- ocds-ted-828775-2025news aktuell GmbH€38.0K12 Dec 2025 IT
Other wins · BG Hexal 1 A Pharma GbR
4 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-124386-2024-6GWQ ServicePlus AGNot disclosed29 Feb 2024 Healthcare
- ocds-ted-467735-2025-7DAK-GesundheitNot disclosed17 Jul 2025 Healthcare
- ocds-ted-474338-2025-6GWQ ServicePlus AGNot disclosed21 Jul 2025 Healthcare
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for DAK-Gesundheit and BG Hexal 1 A Pharma GbR — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back